# About Ipamorelin Order — Editorial method and standing > Ipamorelin Order is an independent editorial project that publishes summaries of the peer-reviewed research literature on ipamorelin. Not a clinic, not a vendor, not a source of medical advice. ## What this is Ipamorelin Order is an independent editorial project that publishes summaries of the peer-reviewed research literature on ipamorelin. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science. The domain modifier — *order* — is editorial framing. A broadside in 1790 was a single-sheet posting setting out an order of items: an order of the evening, an order of business, a playbill listing the order of acts. The ipamorelin research literature reads naturally as such an order — the 1998 discovery paper, the 1999 pharmacokinetic study, the rodent bone and motility studies, the one Phase 2 trial, the 2024 regulatory order — and the site is structured to present that order honestly. The word does not refer to ordering a product, ordering a prescription, or any commercial transaction. The site does not transact. ## Editorial method Three rules govern what appears on this site. First, every quantitative claim is sourced. Doses, half-lives, sample sizes, p-values, ED50 figures, percentage outcomes — each carries an inline numbered citation that maps to the references index. Where a number cannot be cited to a peer-reviewed source or a primary regulatory document, the number does not appear. Second, no recommendation is made. The literature describes what was studied, in what species, at what dose, by what route, for what duration, with what measured outcome. The site reports that. The site does not translate research-context exposures into recommended human doses, does not suggest stacking patterns, does not endorse vendors, and does not offer protocols. Third, the editorial voice is the broadside register — measured, declarative, ordered. Where the literature is ambiguous, the posting says so. Where a trial missed its endpoint, the posting reports the result and the p-value. Where the regulatory record is current, the posting cites the 2024 Pharmacy Compounding Advisory Committee meeting and the September 2024 Federal Register action by name. ## What this is not This is not a clinic. There are no clinicians on staff. No one here writes prescriptions, conducts consultations, reviews labs, or offers any form of medical advice — the publisher is an editorial project, not a healthcare provider. This is not a vendor. The site does not sell ipamorelin or any other compound. It does not list pricing, does not maintain a shopping cart, does not refer readers to any specific supplier, and is not affiliated with any compounding pharmacy, research-chemical marketplace, or laboratory. This is not advice. The compound described is not approved by the United States Food and Drug Administration or any major regulatory agency for any human indication. Its use in any human is not endorsed, recommended, or suggested by anything on this site. This is not a manuscript. The broadside register is editorial, not academic — the site does not pretend to be a primary research publication. The work it summarizes is the primary publication; this site is commentary. ## On the broadside framing The broadside as a printed form has been around since the late seventeenth century — a single sheet, printed on one side, posted on a wall or pillar in a market square. Print-shops produced them as public notices, as playbills, as ordinances, as orders of business. The form is honest about itself: it does not pretend to be a book, and it does not pretend to be a newspaper. It is a sheet of type, set in mixed sizes, sealed by ink-bars, read top to bottom in one sitting. The medium is the message: a public posting, made available for anyone to read. That is the editorial conceit of this site. The ipamorelin research record is, when you set it down, exactly long enough for a broadside — a single ordered posting that the reader can take in across a few minutes. We have set it accordingly. --- For research purposes only. Not for human consumption. This site does not sell any product and is not affiliated with any vendor.